跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
萨兰卡 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Lenacapavir Sodium Injection
Approved
化学药品
Lenacapavir Sodium Injection
GILEAD SCIENCES IRELAND UC
🇨🇳 National Medical Products Administration
Approval Date
Dec 25, 2024
Approval ID
8fv53UmAFUp
Company
GILEAD SCIENCES IRELAND UC
Type
化学药品
Approval Details
Approval Id
8fv53UmAFUp
Approval Number
国药准字HJ20240170
Generic Name
来那帕韦钠注射液
Generic Name En
Lenacapavir Sodium Injection
Trade Name
萨兰卡
Drug Type
化学药品
Dosage Form
注射剂
Strength
1.5ml:0.4635g(按C₃₉H₃₂ClF₁₀N₇O₅S₂计)
Reg Date
2024-12-25
Expired Date
2029-12-24
Company Name
GILEAD SCIENCES IRELAND UC
Production Company Name
PATHEON ITALIA SPA
Company Detail Path
/organization/gilead-sciences-ireland-uc
Production Company Detail Path
/organization/patheon-italia-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 25, 2024
Approval ID
8fv53UmAFUp
Type
化学药品
Back to NMPA Approvals